Peripheral/Endo

Altavant Sciences Advances Rodatristat Ethyl into Phase 2b Clinical Trial for Pulmonary Arterial Hypertension

Cary, N.C. and Basel, Switzerland, May 06, 2021 (GLOBE NEWSWIRE) — Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced today that the company has initiated its ELEVATE 2 Study, a Phase 2b clinical trial of its lead product candidate, rodatristat ethyl (“rodatristat”), for the […]

Micro Medical Solutions Receives FDA Breakthrough Device Designation for MicroStent Vascular Stent

Breakthrough Designation Helps Advance Treatment Options, Targeting a Significant Unmet Need in the Treatment of CLTI. WILMINGTON, Mass., May 4, 2021 /PRNewswire/ — Micro Medical Solutions (MMS), an emerging leader in the treatment of CLTI, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its […]

Journal of Medical Economics Article Demonstrates Economic Benefits of Cardiovascular Systems Orbital Atherectomy in the Treatment of Peripheral Artery Disease (PAD)

Lower cumulative procedure costs at one- and two-years when orbital atherectomy used ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that a new article published in the Journal of […]

Confluent Medical Announces Strategic Investment in The Electrospinning Company

Confluent Medical Invests in The Electrospinning Company to Expand Design Options Utilized in Structural Heart Markets SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies Inc. (Confluent) announced today a strategic investment in The Electrospinning Company Ltd. (Electrospinning). Electrospinning, a UK-based company, has developed a proprietary electrospinning process which will expand the design options […]

Modern Vascular Brings Technology and Innovation to Reduce Unnecessary Limb Loss in Indiana

Indianapolis Chamber of Commerce will hold a ribbon-cutting ceremony on April 29. INDIANAPOLIS, April 26, 2021 /PRNewswire/ — Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of Peripheral Artery Disease (PAD), today announced the expansion of its national footprint to 14 clinics with the opening of a new […]

Innovative Medical Communications Announces Launch of Outpatient Endovascular & Surgical Journal

WEST CHESTER, Pa., April 29, 2021 /PRNewswire/ — Innovative Medical Communications is delighted to announce the launch of Outpatient Endovascular & Surgical Journal, www.oesj.info, a new publication providing health-care communications for clinicians and fellows who have a clinical focus on outpatient endovascular and surgical procedures. Through clinical manuscripts, technology assessments, expert interviews, topical discussion […]

BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula

FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treated in the post-market surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with […]

Vascular Therapies Announces Clinical Results From Its Phase 3 Randomized Multicenter Clinical Trial

– Sirogen™ Shows Encouraging AV Fistula Outcomes in Elderly End-Stage Renal Disease Patients – CRESSKILL, N.J.–(BUSINESS WIRE)–Vascular Therapies, a privately held biotechnology company is developing Sirogen™, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today the company announced clinical results from its Phase […]

Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System – Peripheral (14P)

MONTREAL–(BUSINESS WIRE)–Soundbite announces FDA 510(k) Approval for SoundBite® Crossing System – Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SoundBite® Crossing System – Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional guidewires or treatment devices in the intraluminal space beyond chronic total occlusions (CTOs) in […]

enlightenVue Receives Notice of Allowance for Expanded U.S. Patent Claims for Vascular Diagnostic and Therapeutic Applications of its Single-Use Micro-endoscope Platform

DENVER–(BUSINESS WIRE)–enlightenVue, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for expanded claims for vascular diagnostic and therapeutic applications of its SurgiVue™ single-use micro-endoscope platform. The Notice of Allowance builds on a patent issued in June 2020 covering vascular applications. […]